Actonel (risedronate), a new drug for Paget's disease

Procter and Gamble is now marketing Actonel (risedronate), a new drug for Paget's disease.

Actonel is a bisphosphonate...similar to Fosamax.

Patients take 30 mg of Actonel once daily for 2 months.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote